651 Stock Chart & Stats
€0.01
>-€0.01(-1.25%)
At close: 4:00 PM EST
€0.01
>-€0.01(-1.25%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00K
Market Cap
€2.68M
Enterprise Value€26.92M
Total Cash (Recent Filing)€25.64M
Total Debt (Recent Filing)€12.31M
Price to Earnings (P/E)―
Beta11.04
Next Earnings
Oct 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding1,025,575,800
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€12.49M
Bulls Say, Bears Say
Bulls Say
Industry Focus & Product OfferingLifeClean’s specialized focus on infection control and proprietary disinfection chemistry targets durable demand in healthcare and professional hygiene. The combination of products plus implementation support raises customer switching costs and positions the company to capture ongoing institutional procurement cycles and long-term contracts.
Top-line MomentumSustained revenue growth (TTM +20%) indicates improving market adoption of products and distribution reach. Persistent top-line momentum, if maintained, can help absorb fixed costs, enable scale efficiencies, and provide a platform for improving margins and reducing reliance on external financing over the medium term.
Reduction In Total DebtMaterial reduction in total debt relative to prior years eases immediate refinancing pressure and interest burden. A declining absolute debt level improves optionality for management to prioritize operational fixes and invest in growth, strengthening the balance sheet over a multi-quarter horizon if the trend continues.
Bears Say
Negative Gross ProfitabilityNegative gross profit indicates the company is not covering direct product costs, implying a structurally unprofable unit economics unless pricing, mix, or production costs change. Persisting negative gross margins undermine leverage benefits from revenue growth and make sustainable profitability dependent on material operational changes.
Persistent Cash BurnLarge and persistent negative operating and free cash flow signal ongoing cash burn that prevents self‑funding of operations. Over multiple quarters this forces reliance on external financing or dilution, constrains investment in go‑to‑market and R&D, and elevates the risk of interrupted growth or restructuring.
High Leverage And Thin EquityVery high debt-to-equity and thin or negative equity reduce financial flexibility and increase refinancing and covenant risk. In a loss-making, cash‑burning business, elevated leverage raises the probability of distress or dilutive capital raises, limiting the company's ability to execute strategic plans without external support.
LifeClean International AB News
651 FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is €2.68M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Oct 23, 2026 which is in 104 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Jul 09, 2026. The company reported >-€0.001 earnings per share for the quarter, missing the consensus estimate of N/A by >-€0.001.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of >-€0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in DE:651
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) is a Swedish company that engages in the comprehensive process of investigating, manufacturing, promoting, and distributing disinfection agents within Sweden. A key innovation from the company is its patented surface disinfectant. This powerful formula is engineered to eradicate a wide array of harmful microorganisms, including spores, fungi, tenacious biofilms, bacteria, and viruses. It is designed for versatile application across various equipment and surfaces, encompassing flooring, walls, furniture, and overhead structures. The enterprise was founded in 2012 and maintains its operational base in Uddevalla, Sweden.